CLINICAL_TRIALS
trial_result
· 2017-04-04
Clinical Trial Update: A Double Blind Study in Pediatric Subjects With Chronic Plaque Psoriasis, Studying Adalimumab vs. Methotrexate [Phase 3]
Summary
Phase 3 pediatric trial comparing adalimumab to methotrexate in chronic plaque psoriasis; study completed with results posted in 2017.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: AbbVie (prior sponsor, Abbott) | Conditions: Plaque Psoriasis | Phase 3 | Status: COMPLETED | Results posted: 2017-04-04